secwatch.observer — SEC 8-K summary
======================================

Issuer:     Better Therapeutics, Inc. (—)
CIK:        0001832415
Form:       8-K
Filed at:   2024-03-14T23:59:59+00:00
Accession:  0001193125-24-067483
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Better Therapeutics to terminate employees, seek wind-down or sale after Nasdaq delisting
--------------------------------------------------------------------------------

- Board decided March 13, 2024 to terminate all employees and explore strategic alternatives including assignment for creditors or wind-down.
- Company voluntarily requested delisting from Nasdaq; expects near-term delisting and intends to file Form 15 to suspend SEC reporting.
- No financial terms disclosed; company had been non-compliant with Nasdaq min bid price and market value since Dec 2023.
- Stock symbol BTTX on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832415/000119312524067483/0001193125-24-067483-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832415/000119312524067483/d792547d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-067483

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer